Pathagility is a company.
Key people at Pathagility.
Pathagility was founded by Kristian Andersen (Co-Founder).
Key people at Pathagility.
Pathagility is a customizable laboratory information system (LIS) and laboratory information management system (LIMS) platform designed to adapt to any test type, device, or laboratory workflow, enabling community and regional labs to compete with larger national players.[1][2] It serves laboratories in pathology, genomics, and clinical testing by solving challenges like integration with diverse technologies, cost efficiency, and scalability across multi-location networks or complex reference relationships.[4][5][8] The platform supports growth by offering stand-alone or integrated deployments that unify data visibility, cut costs, and improve efficiency, as evidenced by partnerships like Advanced Genomics using it for clinical lab and genomics expansion.[3][8]
Pathagility emerged to empower community and regional laboratories with technology that levels the playing field against large national labs, focusing on adaptable software for evolving diagnostic needs.[2] While specific founding year and founders are not detailed in available sources, the company has been active since at least 2011, participating in industry discussions on mobile lab integration as noted in CAP Today.[9] Early development emphasized smart technology for cost-effective implementations and standards-based integration, building on a mission to redefine lab operations through flexible LIS solutions, as highlighted in connections to NovoPath's innovative platform.[6][7]
Pathagility rides the trend of digital transformation in laboratory diagnostics, where rising demands for personalized medicine, genomics, and rapid testing require agile software amid hardware diversity and regulatory pressures.[3][4] Its timing aligns with post-pandemic lab expansions and the shift toward integrated, data-unified platforms that enable smaller labs to scale efficiently against giants.[2][8] Market forces like cost pressures on regional labs and the need for mobile/interoperable solutions favor its model, influencing the ecosystem by democratizing advanced LIS/LIMS access and fostering innovation in pathology and clinical workflows.[9]
Pathagility is poised to expand as labs increasingly adopt hybrid, AI-enhanced systems for precision medicine and multi-omics testing, potentially deepening integrations with AI analytics and cloud services. Trends like regulatory pushes for data interoperability and genomics growth will shape its trajectory, amplifying its role in enabling smaller players' competitiveness. Its influence may evolve by powering more consortiums and partnerships, solidifying its niche in adaptive lab tech and tying back to its core mission of growth-enabling software for an underserved market.[1][3]
Pathagility was founded by Kristian Andersen (Co-Founder).
